Prof. Dr. Steffi Lehmann

Work at ZHAW

Position

• Head of Pharmaceutical Technology / Pharmacology Group
• Head of MSc Specialization in Pharmaceutical Biotechnology

Professional development teaching

CAS Detergents & Cosmetics

Projects

• PERISINK – Control of the Peripheral sink and thus serum half-life of biologics via harnessing glycan-specific internalisation / Project leader / ongoing
• Adcancing drug development: 3D CoSeedis Immuno-Micro-Tumor System / Project leader / ongoing
• Zebrafish larvae for drug screening / Project leader / ongoing
• Local brain retention for better brain cancer drugs / Deputy project leader / ongoing
• Imaging of CAR macrophage efficacy / Project leader / completed
• SpectralPad / Co-project leader / completed
• Targeting Gram-negative bacteria / Deputy project leader / completed
• Novel phage derived antimicrobials / Project leader / completed
• Active modified surfaces for contained drug release / Project leader / completed
• “One-tube" luminescent reporter phage testing platform for on-site, lab-free environmental monitoring of Listeria spp. / Co-project leader / completed
• Extracellular vesicles for targeted delivery of new antimicrobials / Project leader / completed
• Infused Drinking Water from Dropz / Deputy project leader / completed
• Development of novel tablet formulations for the detection of pathogenic bacteria / Project leader / completed
• Preventing capsular contracture by coating of silicone implants with bioglass / Project leader / completed

Publications

Articles in scientific journal, peer-reviewed

• Zwicky, J. et al. (2026) ‘Multimodal optical system for quantitative discrimination of bilirubin species’, Biomedical Optics Express, 17(3), pp. 1462–1475. doi: 10.1364/boe.583874.
• Roehrig, C. et al. (2024) ‘MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections’, mBio, 15(2), pp. e02540–23. doi: 10.1128/mbio.02540-23.
• Sabani, B. et al. (2023) ‘A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging’, Nanomedicine: Nanotechnology, Biology and Medicine, 47(102607). doi: 10.1016/j.nano.2022.102607.

Other publications

Sabani B, Brand M, Albert I, Inderbitzin J, Eichenseher F, Schmelcher M, Rohrer J, Riedl R, Lehmann S. A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging. Nanomedicine. 2023 Jan;47:102607. doi: 10.1016/j.nano.2022.102607. Epub 2022 Sep 24. PMID: 36167305.

go back